ADHD-hyperactive/impulsive subtype in adults

Mental Illness

Volumn 2, Issue 1, 2010, Pages 41-45

  Gibbins, Christopher ^a   Weiss, Margaret D ^a,b   Goodman, David W ^c,d   Hodgkins, Paul S ^e   Landgraf, Jeanne M ^f   Faraone, Stephen V ^g  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Adult Attention Deficit Disorder Center of Maryland   (United States)

^e SHIRE   (United States)

^f HealthActCHQ   (United States)

^g SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

ADHD; Adult; Attention deficit; Quality of life; Subtypes

Indexed keywords

EID: 80053595906     PISSN: 20367457     EISSN: 20367465     Source Type: Journal    
DOI: 10.4081/mi.2010.e9     Document Type: Article

References (34)

1. Lahey BB, Applegate B. Validity of DSM-IV ADHD. J Am Acad Child Adolesc Psychiatry 2001;40:502-4
2. Lahey BB, Applegate B, McBurnett K, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 1994;151:1673-85.
3. Woo BS, Rey JM. The validity of the DSMIV subtypes of attention-deficit/hyperactivity disorder. Aust N Z J Psychiatry 2005;39:344-53.
4. Lahey BB, Pelham WE, Stein MA, et al. Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry 1998;37:695-702.
5. Faraone SV, Biederman J, Friedman D. Validity of DSM-IV subtypes of attentiondeficit/hyperactivity disorder: a family study perspective. J Am Acad Child Adolesc Psychiatry 2000;39:300-7.
6. Geurts HM, Verté S, Oosterlaan J, et al. ADHD subtypes: do they differ in their executive functioning profile? Arch Clin Neuropsychol 2005;20:457-77.
7. Faraone SV, Biederman J, Weber W, Russell RL. Psychiatric, neuropsychological, and psychosocial features of DSM-IV subtypes of attention-deficit/hyperactivity disorder: results from a clinically referred sample. Am Acad Child Adolesc Psychiatry 1998;37:185-93.
8. Marshall RM, Hynd GW, Handwerk MJ, Hall J. Academic underachievement in ADHD subtypes. J Learn Disabil 1997;30:635-42.
9. Todd RD, Sitdhiraksa N, Reich W, et al. Discrimination of DSM-IV and latent class attention-deficit/hyperactivity disorder subtypes by educational and cognitive performance in a population-based sample of child and adolescent twins. J Am Acad Child Adolesc Psychiatry 2002;41:820-8.
10. Chhabildas N, Pennington BF, Willcutt EG. A comparison of the neuropsychological profiles of the DSM-IV subtypes of ADHD. J Abnorm Child Psychol 2001;29:529-40.
11. de Nijs PF, Ferdinand RF, Verhulst FC. No hyperactive-impulsive subtype in teacherrated attention-deficit/hyperactivity problems. Eur Child Adolesc Psychiatry 2007;16:25-32.
12. Schweitzer JB, Hanford RB, Medoff DR. Working memory deficits in adults with ADHD: is there evidence for subtype differences? Behav Brain Funct 2006;2:43.
13. Smalley SL, McGough JJ, Moilanen IK, et al. Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population. J Am Acad Child Adolesc Psychiatry 2007;46:1575-83.
14. Graetz BW, Sawyer MG, Hazell PL, et al. Validity of DSM-IVADHD subtypes in a nationally representative sample of Australian children and adolescents. Am Acad Child Adolesc Psychiatry 2001;40:1410-7.
15. Lahey BB, Pelham WE, Loney J, et al. Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry 2005;62:896-902.
16. Weiss M, Worling D, Wasdell M. A chart review study of the inattentive and combined types of ADHD. J Atten Disord 2003;7:1-9.
17. Mick E, Faraone SV, Biederman J. Agedependent expression of attentiondeficit/hyperactivity disorder symptoms. Psychiatr Clin North Am 2004;27:215-24.
18. Adler LA. Clinical presentations of adult patients with ADHD. J Clin Psychiatry 2004;65 Suppl 3:8-11.
19. Sprafkin J, Gadow KD, Weiss MD, et al. Psychiatric comorbidity in ADHD symptom subtypes in clinic and community adults. J Atten Disord 2007;11:114-24.
20. Smidts DP, Oosterlaan J. How common are symptoms of ADHD in typically developing preschoolers? A study on prevalence rates and prenatal/demographic risk factors. Cortex 2007;43:710-7.
21. Posner K, Melvin GA, Murray DW, et al. Clinical presentation of attentiondeficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol 2007;17:547-62.
22. Hardy KK, Kollins SH, Murray DW, et al. Factor structure of parent- and teacherrated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol 2007;17:621-34.
23. Hurtig T, Ebeling H, Taanila A, et al. ADHD symptoms and subtypes: relationship between childhood and adolescent symptoms. J Am Acad Child Adolesc Psychiatry 2007;46:1605-13.
24. Todd RD, Huang H, Todorov AA, et al. Predictors of stability of attentiondeficit/hyperactivity disorder subtypes from childhood to young adulthood. J Am Acad Child Adolesc Psychiatry 2008;47:76-85.
25. Biederman J, Mick E, Faraone SV. Agedependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000;157:816-8.
26. Goodman DW, Ginsberg L, Weisler RH, et al. An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 2005;10:26-34.
27. Zhang S, Faries DE, Vowles M, Michelson D. ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res 2005;14:186-201.
28. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992; 49:624-9.
29. Guy W. ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publ No ADM 76-338). Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Services, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976
30. Scott KM, Tobias MI, Sarfati D, Haslett SJ. SF-36 health survey reliability, validity and norms for New Zealand. Aust N Z J Public Health 1999;23:401-6.
31. Landgraf JM. Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord 2007;11:351-62.
32. Weiss MD, Gibbins C, Goodman DW, et al. Moderators and mediators of symptoms and quality of life outcomes in an openlabel study of adults treated for attentiondeficit/hyperactivity disorder. J Clin Psychiatry 2010;71:381-90.
33. Achenbach TM, Howell CT, McConaughy SH, Stanger C. Six-year predictors of problems in a national sample: IV. Young adult signs of disturbance. J Am Acad Child Adolesc Psychiatry 1998;37:718-27.
34. Mick E, Faraone SV, Biederman J. Agedependent expression of attention-deficit/hyperactivity disorder symptoms. Psychiatr Clin North Am 2004;27:215-24.